pharma · Leiomyosarcoma · Friedreich Ataxia
PTC Therapeutics Iberia
PTC Therapeutics International Limited
PTC Therapeutics International is a pharma organization headquartered in DUBLIN, IE. Primary therapeutic focus areas include Leiomyosarcoma, Friedreich Ataxia. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s
Madrid, ES HQ
1998 Founded
5 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Madrid, ES
- Founded
- 1998
- Employees
- 5
- Programs
- 2
- Drugs
- 0
- Patents
- 0
Vatiquinone
Phase 3 · small molecule · Friedreich Ataxia
Vatiquinone for Friedreich Ataxia is a Phase 3 program (small_molecule) at PTC Therapeutics International Limited with 1 ClinicalTrials.gov record(s).
Internal code PTC743-NEU-003e-FA
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- PTC Therapeutics International Limited
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Friedreich Ataxia
- Status
- active
- Trials
- 1